JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A8708 Sephin1
1 Citation

Target: phosphatases

Summary: Selective PPP1R15A inhibitor

insoluble in H2O; insoluble in EtOH; ≥7.75 mg/mL
B5959 GSK J4 free base

Summary: histone demethylase JMJD3/UTX inhibitor
B5868 MK3102

Summary: Novel long-acting DPP-4 inhibitor

insoluble in EtOH; insoluble in H2O; ≥17.15 mg/mL
B5954 Dasatinib Monohydrate

Target: PDGFR|c-Kit|Bcr-Abl|Src

Summary: Inhibitor of ABL, SRC, KIT, PDGFR, and other tyrosine kinases.

≥25.3 mg/mL
C5708 α-Guanidinoglutaric Acid

Summary: linear mixed-type inhibitor of nNOS
C5723 S-(2-aminoethyl) Isothiourea (dihydrobromide)

Summary: non-selective inhibitor of all NOS isoforms

≤10 mg/mL
A8764 Rapalink-1
5 Citation

Target: mTOR

Summary: third-generation mTOR inhibitor

≥178.4 mg/mL
L1049 DiscoveryProbe™ Ubiquitination Compound Library

Summary: A collection of 144 ubiquitination compounds supplied as lyophilized powder or pre-dissolved DMSO solutions
A1033 [Ser25] Protein Kinase C (19-31)

Summary: PKC substrate

insoluble in EtOH; ≥155.9 mg/mL
C6532 MES sodium salt

≥38.6 mg/mL